首页 >>2016年02期
细菌性腹泻免疫预防专家共识
作者:《细菌性腹泻免疫预防专家共识》专家组

摘要:

关键词:腹泻;免疫;疫苗;预防

Abstract:

Key words: Diarrhea;Immunity;Vaccine;Prevention

发表日期:2016/2

引用本文:

图/表:

    暂无图表

参考文献:

[1]Fischer WalkerCL, SackD, BlackRE. 2010. Etiology of diarrhea in older children, adolescents and adults: a systematic review[J]. PLoS Negl Trop Dis, 2010, 4(8):e768. DOI: 10.1371/journal.pntd.0000768.
[2]KotloffKL, NataroJP, BlackwelderWC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study[J]. Lancet, 2013, 382(9888):209-222. DOI: 10.1016/S0140-6736(13)60844-2.
[3]LiuL, OzaS, HoganD, et al. Global, regional, and national causes of child mortality in 2000-2013, with projections to inform post-2015 priorities: an updated systematic analysis[J]. Lancet, 2015, 385(9966): 430-440. DOI: 10.1016/S0140-6736(14)61698-6.
[4]HuilanS, ZhenLG, MathanMM, et al. Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries[J]. Bull World Health Organ, 1991, 69(5):549-555.
[5]于国慧,董方,甄景慧,等.北京地区儿童感染性腹泻病原学和耐药性分析[J].临床儿科杂志,2010,28(6):535-538.
[6]秦小玄,朱朝敏.致泻性大肠杆菌的流行及耐药现状[J].儿科药学杂志,2008,14(2):61-64.
[7]ScallanE, GriffinPM, AnguloFJ, et al. Foodborne illness acquired in the United States-unspecified agents[J]. Emerg Infect Dis, 2011, 17(1):16-22. DOI: 10.3201/eid1701.091101p2.
[8]ThomasMK, MurrayR, FlockhartL, et al. Estimates of Foodborne illness-Related Hospitalizations and Deaths in Canada for 30 Specified Pathogens and Unspecified Agents[J]. Foodborne Pathog Dis, 2015, 12(10): 820-827. DOI: 10.1089/fpd.2015.1966.
[9]张静,刘民.广东、河南、甘肃三省12县区腹泻病例就诊模式调查[J].中华流行病学杂志,2008,29(10):989-993.
[10]毛雪丹,胡俊峰,刘秀梅.我国细菌性食源性疾病疾病负担的初步研究[J].中国食品卫生杂志,2011,23(2):132-136.
[11]QuM, DengY, ZhangX, et al. Etiology of acute diarrhea due to enteropathogenic bacteria in Beijing, China[J]. J Infect, 2012, 65(3): 214-222. DOI: 10.1016/j.jinf.2012.04.010.
[12]ZhuM, CuiS, LinL, et al. Analysis of the aetiology of diarrhoea in outpatients in 2007, Henan province, China[J]. Epidemiol Infect, 2013, 141(3): 540-548. DOI: 10.1017/S0950268812000970.
[13]费怡,孙乔,傅益飞,等.上海市浦东新区5岁以下儿童腹泻病病原谱监测分析[J].上海预防医学,2013,(11):602-605.
[14]聂青和.感染性腹泻的研究现状[J].传染病信息,2007,20(4):193-196.
[15]世界卫生组织.腹泻治疗:医生和高年资卫生工作者使用手册[M].4版.日内瓦:世界卫生组织,2005.
[16]World Health Organization. Cholera, 2013[J]. Wkly Epidemiol Rec, 2014, 89(31): 345-356.
[17]李凤祥,计国欣,曾明.细菌性腹泻病疫苗的研究进展[J].微生物学免疫学进展,2008,36(4):91-95.
[18]阚飙.霍乱口服疫苗的研究与应用[J].中华预防医学杂志,2015,49(2):105-109. DOI: 10.3760/cma.j.issn.0253-9624.2015.02.001.
[19]World Health Organization. Cholera vaccines: WHO position paper[J]. Wkly Epidemiol Rec, 2010, 85(13):117-128. DOI: 10.1016/j.vaccine.2010.05.008.
[20]HolmgrenJ, AdamssonJ, AnjuèreF, et al. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA[J]. Immunol Lett, 2005, 97(2):181-188. DOI: 10.1016/j.imlet.2004.11.009.
[21]ClemensJD, SackDA, HarrisJR, et al. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial[J]. J Infect Dis, 1988, 158(2): 372-377. DOI: 10.1093/infdis/158.2.372.
[22]PeltolaH, SiitonenA, Kyr?nsepp?H, et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine[J]. Lancet, 1991, 338(8778):1285-1289. DOI: 10.1016/0140-6736(91)92590-X.
[23]ClemensJD, SackDA, HarrisJR, et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up[J]. Lancet, 1990, 335(8684): 270-273. DOI: 10.1016/0140-6736(90)90080-O.
[24]ClemensJD, HarrisJR, SackDA, et al. Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up[J]. J Infect Dis, 1988, 158(1): 60-69. DOI: 10.1093/infdis/158.1.60.
[25]SanchezJL, VasquezB, BegueRE, et al. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits[J]. Lancet, 1994, 344(8932): 1273-1276. DOI: 10.1016/S0140-6736(94)90755-2.
[26]LucasME, DeenJL, von SeidleinL, et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique[J]. N Engl J Med, 2005, 352(8): 757-767. DOI: 10.1056/NEJMoa043323.
[27]TrachDD, ClemensJD, KeNT, et al. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam[J]. Lancet, 1997, 349(9047): 231-235. DOI: 10.1016/S0140-6736(96)06107-7.
[28]ThiemVD, DeenJL, von SeidleinL, et al. Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam[J]. Vaccine, 2006, 24(20): 4297-4303. DOI: 10.1016/j.vaccine.2006.03.008.
[29]López-GigososR, Garcia-ForteaP, CalvoMJ, et al. Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea[J]. BMC Infect Dis, 2009, 9: 65. DOI: 10.1186/1471-2334-9-65.
[30]López-GigososR, García-ForteaP, Reina-Do?aE, et al. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS[J]. Travel Med Infect Dis, 2007, 5(6): 380-384. DOI: 10.1016/j.tmaid.2007.06.001.
[31]甄蓓,俞守义,陈清,等.冻干口服霍乱rBS-WC疫苗现场试验及评价[J].中国计划免疫,1999,9(4):210-214.
[32]时念民,罗凤基,李书明,等.大学生与务工人员服用口服重组B亚单位霍乱疫苗的安全性及效果分析[J].中华医学杂志,2010,90(3):192-195. DOI: 10.3760/cma.j.issn.
[33]AnwarE, GoldbergE, FraserA, et al. Vaccines for preventing typhoid fever[J]. Cochrane Database Syst Rev, 2014, 1: CD001261. DOI: 10.1002/14651858.CD001261.
[34]SurD, OchiaiRL, BhattacharyaSK, et al. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India[J]. N Engl J Med, 2009, 361(4):335-344. DOI: 10.1056/NEJMoa0807521.
[35]KhanMI, SoofiSB, OchiaiRL, et al. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan[J]. Vaccine. 2012, 30(36):5389-5395. DOI: 10.1016/j.vaccine.2012.06.015.
[36]MahonBE, NewtonAE, MintzED. Effectiveness of typhoid vaccination in US travelers[J].Vaccine, 2014, 32(29):3577-3579. DOI: 10.1016/j.vaccine.2014.04.055.
[37]YangHH, KilgorePE, YangLH, et al. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine[J]. J Infect Dis, 2001, 183(12):1775-1780. DOI: 10.1086/320729.

用户评论 0条

用户名: 密码: 登陆 注册
 
  • 9
  • 3
  •  4 : 页次:0/0页 共0条记录 5条/每页
    关于我们 | 专家风采 | 会员注册 | 继续教育
    地 址:北京市西城区东河沿街69号正弘大厦511室 邮 编:100052
    电话:010-51322302
    版权所有 中华医学会及中华预防医学杂志编辑部
    京ICP备 07035254 号